1. Home
  2. EPRT vs RGEN Comparison

EPRT vs RGEN Comparison

Compare EPRT & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EPRT
  • RGEN
  • Stock Information
  • Founded
  • EPRT 2016
  • RGEN 1981
  • Country
  • EPRT United States
  • RGEN United States
  • Employees
  • EPRT N/A
  • RGEN N/A
  • Industry
  • EPRT Real Estate Investment Trusts
  • RGEN Medical/Dental Instruments
  • Sector
  • EPRT Real Estate
  • RGEN Health Care
  • Exchange
  • EPRT Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • EPRT 6.2B
  • RGEN 6.5B
  • IPO Year
  • EPRT 2018
  • RGEN N/A
  • Fundamental
  • Price
  • EPRT $29.93
  • RGEN $119.39
  • Analyst Decision
  • EPRT Strong Buy
  • RGEN Buy
  • Analyst Count
  • EPRT 10
  • RGEN 10
  • Target Price
  • EPRT $35.20
  • RGEN $163.78
  • AVG Volume (30 Days)
  • EPRT 1.4M
  • RGEN 718.1K
  • Earning Date
  • EPRT 10-22-2025
  • RGEN 11-11-2025
  • Dividend Yield
  • EPRT 4.01%
  • RGEN N/A
  • EPS Growth
  • EPRT 1.76
  • RGEN N/A
  • EPS
  • EPRT 1.19
  • RGEN N/A
  • Revenue
  • EPRT $503,256,000.00
  • RGEN $673,956,000.00
  • Revenue This Year
  • EPRT $22.76
  • RGEN $16.79
  • Revenue Next Year
  • EPRT $16.73
  • RGEN $13.68
  • P/E Ratio
  • EPRT $25.13
  • RGEN N/A
  • Revenue Growth
  • EPRT 25.14
  • RGEN 8.73
  • 52 Week Low
  • EPRT $27.44
  • RGEN $102.97
  • 52 Week High
  • EPRT $34.88
  • RGEN $182.52
  • Technical
  • Relative Strength Index (RSI)
  • EPRT 43.11
  • RGEN 49.56
  • Support Level
  • EPRT $29.26
  • RGEN $112.73
  • Resistance Level
  • EPRT $30.12
  • RGEN $122.71
  • Average True Range (ATR)
  • EPRT 0.47
  • RGEN 4.85
  • MACD
  • EPRT -0.10
  • RGEN -0.27
  • Stochastic Oscillator
  • EPRT 32.21
  • RGEN 53.02

About EPRT Essential Properties Realty Trust Inc.

Essential Properties Realty Trust Inc is a real estate investment trust. It is an internally managed real estate company acquires, owns and manages single-tenant properties that are net leased on a long-term basis to middle-market companies operating service-oriented or experience-based businesses. The Company generally invests in and leases freestanding, single-tenant commercial real estate facilities where a tenant services its customers and conducts activities that are essential to the generation of the tenant's sales and profits.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: